Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Acta Neuropathologica
|
December 24, 2017
Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis
Christopher M Henstridge, Dimitrios I Sideris, Emily Carroll, et al.
Journal of Neurology
|
December 14, 2022
Genotype-phenotype characterisation of long survivors with motor neuron disease in Scotland
Danielle J Leighton, Morad Ansari, Judith Newton, et al.
The Lancet. Neurology
|
September 22, 2024
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial
Suvankar Pal, Jeremy Chataway, Robert Swingler, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
March 21, 2019
Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland
Danielle Leighton, Judith Newton, Shuna Colville, et al.
Brain Communications
|
December 13, 2021
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective
Charis Wong, Maria Stavrou, Elizabeth Elliott, et al.
American Journal of Human Genetics
|
June 18, 2024
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
Claudia Manzoni, Demis A Kia, Raffaele Ferrari, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Acta Neuropathologica
|
December 24, 2017
Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis
Christopher M Henstridge, Dimitrios I Sideris, Emily Carroll, et al.
Journal of Neurology
|
December 14, 2022
Genotype-phenotype characterisation of long survivors with motor neuron disease in Scotland
Danielle J Leighton, Morad Ansari, Judith Newton, et al.
The Lancet. Neurology
|
September 22, 2024
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial
Suvankar Pal, Jeremy Chataway, Robert Swingler, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
March 21, 2019
Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland
Danielle Leighton, Judith Newton, Shuna Colville, et al.
Brain Communications
|
December 13, 2021
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective
Charis Wong, Maria Stavrou, Elizabeth Elliott, et al.
American Journal of Human Genetics
|
June 18, 2024
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
Claudia Manzoni, Demis A Kia, Raffaele Ferrari, et al.
Page
of 5